Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Sex-determining region Y (SRY) attributes to gender differences in RANKL expression and incidence of osteoporosis
ID
Kodrič, Klemen
(
Author
),
ID
Zupan, Janja
(
Author
),
ID
Kranjc, Tilen
(
Author
),
ID
Komadina, Radko
(
Author
),
ID
Mlakar, Vid
(
Author
),
ID
Marc, Janja
(
Author
),
ID
Lovšin, Nika
(
Author
)
PDF - Presentation file,
Download
(2,80 MB)
MD5: 8187599342F383A69C533E3E1A4330F7
URL - Source URL, Visit
https://www.nature.com/articles/s12276-019-0294-3
Image galllery
Abstract
Receptor activator of nuclear factor KB ligand (RANKL) plays a crucial role in bone metabolism. RANKL gene misregulation has been implicated in several bone and cancer diseases. Here, we aimed to identify novel transcription regulators of RANKL expression. We discovered that transcription factors, sex-determining region Y (SRY) and c-Myb, regulate RANKL expression. We demonstrated that c-Myb increases and male-specific SRY decreases RANKL expression through direct binding to its 5'-proximal promoter. These results are corroborated by the gene expression in human bone samples. In osteoporotic men, expression of RANKL is 17-fold higher, which correlates with the drastically reduced expression (200-fold) of Sry, suggesting that in osteoporotic men, the upregulation of RANKL is caused by a decrease of Sry. In healthy men, the expression of RANKL is 20% higher than that in healthy women. Our data suggest that gender differences in RANKL expression and bone quality could be due to the sex-specific transcription factor SRY.
Language:
English
Keywords:
genetics
,
metabolic bone disease
,
osteoporosis
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2019
Number of pages:
16 str.
Numbering:
Vol. 51, iss. 8, art. 97
PID:
20.500.12556/RUL-141292
UDC:
616.71-007.234+616-006.3.04
ISSN on article:
2092-6413
DOI:
10.1038/s12276-019-0294-3
COBISS.SI-ID:
4766321
Publication date in RUL:
28.09.2022
Views:
1142
Downloads:
82
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Experimental and molecular medicine
Shortened title:
Exp. mol. medicine
Publisher:
Springer Nature
ISSN:
2092-6413
COBISS.SI-ID:
521612825
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
RANKL
,
SRY protein
,
osteoporoza
,
sarkom
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
J3-7245
Name:
Odkrivanje novih regulatorjev izražanja RANKL, ključne molekule ne samo v kostni prenovi
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0298
Name:
Geni, hormonske in osebnostne spremembe pri metabolnih motnjah
Funder:
ARRS - Slovenian Research Agency
Funding programme:
Young researchers
Funder:
EC - European Commission
Funding programme:
Interreg ITA-SLO
Acronym:
ARTE
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back